Advertisement

Topics

Novocure Announces Departure of Chief Commercial Officer

06:05 EST 23 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Novocure (NASDAQ: NVCR) announced today that its Chief Commercial Officer, Peter Melnyk, will be leaving the company to pursue other interests. Mr. Melnyk will continue his employment with the company until March 15, 2017 to ens...

Other Sources for this Article

Novocure
Ashley Cordova, 212-767-7558
Media and Investor Contact
acordova@novocure.com

NEXT ARTICLE

More From BioPortfolio on "Novocure Announces Departure of Chief Commercial Officer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...